Press Release ::: Current Stem Cell Research & Therapy Registers its 1st Impact Factor

Bentham Press Release -- NEWS

Current Stem Cell Research & Therapy Registers its 1st Impact Factor

News release date: June 27, 2013

Bussum, Netherlands, June 27, 2013: Current Stem Cell Research & Therapy has registered its first Impact Factor at 2.963. The Impact Factor ranking has been awarded by Journal Citation Reports®, which are annually published by the Institute of Scientific Information, a division of Thomson Reuters. Its purpose is to offer a systematic means to critically evaluate the world's leading journals, with quantifiable, statistical information based on citation data.

Current Stem Cell Research & Therapy publishes high quality frontier reviews, drug clinical trial studies and guest edited issues on all aspects of basic research on stem cells and their uses in clinical therapy.


Advertisement

Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science